CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
4.780
+0.190 (4.14%)
Jul 16, 2025, 4:00 PM - Market closed
CapsoVision Market Cap
CapsoVision has a market cap or net worth of $221.52 million as of July 16, 2025.
Market Cap
221.52M
Enterprise Value
209.47M
1-Year Change
n/a
Ranking
Category
Stock Price
4.78
Market Cap Chart
Since the IPO on July 2, 2025, CapsoVision's market cap has decreased from $230.47M to $221.52M, a decrease of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 212.72M | 5.03% |
| Jul 14, 2025 | 202.52M | -4.38% |
| Jul 11, 2025 | 211.79M | 1.56% |
| Jul 10, 2025 | 208.55M | -7.98% |
| Jul 9, 2025 | 226.62M | 6.07% |
| Jul 8, 2025 | 213.65M | 10.02% |
| Jul 7, 2025 | 194.18M | -4.77% |
| Jul 3, 2025 | 203.91M | -11.52% |
| Jul 2, 2025 | 230.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 218.74B |